Latest filing published 15 Sept 2026 for Wuhan YZY Biopharma Co., Ltd. - B - H Shares, €9.5M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Zhou Hongfeng: trading record in brief
This profile gathers the share dealings of Zhou Hongfeng across 2 companies, led by Wuhan YZY Biopharma Co., Ltd. - B and Wuhan YZY Biopharma Co., Ltd. - B - H Shares. We count 4 filings; the first trade dates from 30 March 2026 and the latest from 30 August 2026.
In open-market terms, that means 2 purchases worth €9.5M on one side and 1 sale on the other. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 15 September 2026, the filings show an open-market purchase worth €9.5M in Wuhan YZY Biopharma Co., Ltd. - B - H Shares. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Zhou Hongfeng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,592,400 shares@ HK$2.43100.0% of flowShareXHKGHKEX:DA20260914E00538Canonical exit: 28 Nov 2026 (T+90)
- 1,342,600 sharesShareXHKGHKEX:DA20260616E00173
- 54,262,305 sharesShareXHKGHKEX:DA20260331E00392
- 54,262,305 sharesShareXHKGHKEX:DA20260331E00393Canonical exit: 28 Jun 2026 (T+90)
4 of 3 declarations